1. Home
  2. EMBC vs AIO Comparison

EMBC vs AIO Comparison

Compare EMBC & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • AIO
  • Stock Information
  • Founded
  • EMBC 1924
  • AIO 2019
  • Country
  • EMBC United States
  • AIO United States
  • Employees
  • EMBC N/A
  • AIO N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • AIO Finance/Investors Services
  • Sector
  • EMBC Health Care
  • AIO Finance
  • Exchange
  • EMBC Nasdaq
  • AIO Nasdaq
  • Market Cap
  • EMBC 838.7M
  • AIO 808.3M
  • IPO Year
  • EMBC N/A
  • AIO N/A
  • Fundamental
  • Price
  • EMBC $13.83
  • AIO $23.82
  • Analyst Decision
  • EMBC Buy
  • AIO
  • Analyst Count
  • EMBC 2
  • AIO 0
  • Target Price
  • EMBC $18.50
  • AIO N/A
  • AVG Volume (30 Days)
  • EMBC 514.0K
  • AIO 141.5K
  • Earning Date
  • EMBC 11-25-2025
  • AIO 01-01-0001
  • Dividend Yield
  • EMBC 4.32%
  • AIO 9.05%
  • EPS Growth
  • EMBC 18.26
  • AIO N/A
  • EPS
  • EMBC 1.42
  • AIO N/A
  • Revenue
  • EMBC $1,102,500,000.00
  • AIO N/A
  • Revenue This Year
  • EMBC N/A
  • AIO N/A
  • Revenue Next Year
  • EMBC N/A
  • AIO N/A
  • P/E Ratio
  • EMBC $9.77
  • AIO N/A
  • Revenue Growth
  • EMBC N/A
  • AIO N/A
  • 52 Week Low
  • EMBC $9.20
  • AIO $15.09
  • 52 Week High
  • EMBC $21.48
  • AIO $20.25
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 44.40
  • AIO 42.11
  • Support Level
  • EMBC $13.78
  • AIO $23.76
  • Resistance Level
  • EMBC $14.78
  • AIO $24.38
  • Average True Range (ATR)
  • EMBC 0.53
  • AIO 0.38
  • MACD
  • EMBC -0.14
  • AIO -0.02
  • Stochastic Oscillator
  • EMBC 14.97
  • AIO 16.50

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

Share on Social Networks: